preclinical « Science and Enterprise

Biotech Start-Up to Discover Cystic Fibrosis Therapy

By Alan, on June 19th, 2023%

A new biotechnology company is advancing research to find a comprehensive treatment for cystic fibrosis, and staked to a €2 million seed investment from its founder. . . . → Read More: Biotech Start-Up to Discover Cystic Fibrosis Therapy

Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds

By Alan, on June 7th, 2023%

A developer of nanoscale lipid particles for delivering genomic therapies to specific cells and tissue, spun-off from academic labs, is raising $25 million in seed funds. . . . → Read More: Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds

Safer Forms of Psilocybin Assessed in Preclinical Study

By Alan, on May 22nd, 2023%

A biotechnology company says it identified engineered precursors of a psychedelic compound that in lab animals produce safe and intended therapeutic effects. . . . → Read More: Safer Forms of Psilocybin Assessed in Preclinical Study

Crispr Therapy Shown to Remove E. Coli in Gut

By Alan, on May 5th, 2023%

New research with lab animals shows gene-edited viruses can target and remove harmful E. coli bacteria from the gut, including strains usually resistant to antibiotics. . . . → Read More: Crispr Therapy Shown to Remove E. Coli in Gut

Low-Dose Covid-19 Vaccine Generates Strong Immune Response

By Alan, on April 27th, 2023%

Ultra-low quantities of an experimental Covid-19 protein vaccine delivered in synthetic cell components are shown in lab animals to generate strong immune responses. . . . → Read More: Low-Dose Covid-19 Vaccine Generates Strong Immune Response

Industry, Academic Labs Detailing ALS Treatment Actions

By Alan, on March 27th, 2023%

Researchers from a developer of neurodegenerative disease therapies and university medical center are investigating the precise workings of a promising ALS treatment. . . . → Read More: Industry, Academic Labs Detailing ALS Treatment Actions

Gene Therapy Shown to Build Knee Cartilage

By Alan, on March 13th, 2023%

Findings from research with lab animals shows a single gene therapy injection delivered with a benign virus helps build new knee cartilage cells and tissue. . . . → Read More: Gene Therapy Shown to Build Knee Cartilage

Fox Foundation Funds New Genetic Variation Targets for Parkinson’s

By Alan, on March 8th, 2023%

A Parkinson’s disease organization is giving a grant to a neurodegenerative therapies developer that targets new groups of underlying disease-causing genetic changes. . . . → Read More: Fox Foundation Funds New Genetic Variation Targets for Parkinson’s

Business-Academic Team to Create RNA Delivery for Cancer

By Alan, on March 2nd, 2023%

A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles. . . . → Read More: Business-Academic Team to Create RNA Delivery for Cancer

mRNA Aerosol Delivered to Lungs to Treat Pneumonia

By Alan, on February 28th, 2023%

Messenger RNA, inhaled from an aerosol spray, is shown in lab rats with pneumonia to reduce inflammation, improve lung functions, and protect against further infections. . . . → Read More: mRNA Aerosol Delivered to Lungs to Treat Pneumonia

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise